Abstract Hepatocellular carcinoma (HCC) is one of the most frequent neoplasms worldwide and in most cases it is associated with chronic liver disease. Liver transplantation (LT) is potentially the optimal treatment for those patients with HCC who have a poor functional hepatic reserve due to their underlying chronic liver disease. However, due to the limited availability of donors, only those patients whose oncologic profile is favorable can be considered for LT. Despite the careful selection of candidates based on strict rules, 10 to 20% of liver transplant recipients who have HCC in the native cirrhotic liver develop tumor recurrence after transplantation. The selection criteria presently employed to minimize the risk of recurrence are ba...
Liver transplantation for hepatocellular carcinoma (HCC) in patients with cirrhosis is a radical tre...
Liver transplantation is a treatment for hepatocellular carcinoma in cirrhosis which is both recogni...
Liver transplantation is the best treatment of patients with unresectable early hepatocellular carci...
Hepatocellular carcinoma (HCC) is one of the most frequent neoplasms worldwide and in most cases it ...
Hepatocellular carcinoma represents an important cause of morbidity and mortality worldwide. It is t...
Hepatocellular carcinoma (HCC) is an increasingly common indication for liver transplantation (LT) i...
Background: Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality worldwide. It...
Hepatocellular Carcinoma (HCC) represents the fifth most common malignancy and the third cancer-rela...
Abstract Overall survival and recurrence rates aft er liver transplantation (LT) for hepatocellular ...
Hepatocellular carcinoma (HCC) is an aggressive tumor that often occurs in chronic liver disease and...
Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), occurring in 10–15% o...
Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), occurring in 10–15% o...
The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two decades,...
Liver transplantation for hepatocellular carcinoma : role of immunosuppression and rejection treatme...
Liver transplantation (LT) has originally been designed to treat hepatobiliary malignancies. The ini...
Liver transplantation for hepatocellular carcinoma (HCC) in patients with cirrhosis is a radical tre...
Liver transplantation is a treatment for hepatocellular carcinoma in cirrhosis which is both recogni...
Liver transplantation is the best treatment of patients with unresectable early hepatocellular carci...
Hepatocellular carcinoma (HCC) is one of the most frequent neoplasms worldwide and in most cases it ...
Hepatocellular carcinoma represents an important cause of morbidity and mortality worldwide. It is t...
Hepatocellular carcinoma (HCC) is an increasingly common indication for liver transplantation (LT) i...
Background: Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality worldwide. It...
Hepatocellular Carcinoma (HCC) represents the fifth most common malignancy and the third cancer-rela...
Abstract Overall survival and recurrence rates aft er liver transplantation (LT) for hepatocellular ...
Hepatocellular carcinoma (HCC) is an aggressive tumor that often occurs in chronic liver disease and...
Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), occurring in 10–15% o...
Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), occurring in 10–15% o...
The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two decades,...
Liver transplantation for hepatocellular carcinoma : role of immunosuppression and rejection treatme...
Liver transplantation (LT) has originally been designed to treat hepatobiliary malignancies. The ini...
Liver transplantation for hepatocellular carcinoma (HCC) in patients with cirrhosis is a radical tre...
Liver transplantation is a treatment for hepatocellular carcinoma in cirrhosis which is both recogni...
Liver transplantation is the best treatment of patients with unresectable early hepatocellular carci...